1-9 of 9
Keywords: Tolerability
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2019) 97 (6): 341–347.
Published Online: 28 August 2019
...) received vinflunine (Javlor®) every 3 weeks at 320 mg/m 2 via 20-min intravenous infusion. The endpoints were progression-free survival (PFS), objective response rate, overall survival (OS), and tolerability. The cumulative survival of the patients was analyzed using the Kaplan-Meier method. Results...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2017) 93 (3): 157–163.
Published Online: 23 June 2017
... care” [ 13 ] and which are applied complementarily, i.e., “[…] with standard treatment,” or alternatively, i.e., “[…] instead of standard treatment” [ 13 ]. Complementary medicine Cancer Malignancy Alternative medicine Tolerability Complementary and alternative medicine (CAM) plays...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2014) 87 (1): 30–39.
Published Online: 25 June 2014
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Toxicity Tolerability Renal...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1997) 54 (Suppl. 2): 23–26.
Published Online: 30 June 2009
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tolerability Endocrine treatment Quality of life Assessment Side-effects ONCOLOGY Oncology 1997;54(suppl 2):23 26 U. Kohler1 Department of Gynaecology and Obstetrics, University...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2001) 61 (Suppl. 1): 30–34.
Published Online: 26 September 2001
... the feasibility and tolerability of an oral formulation of topotecan (1.0–1.5 mg/m 2 /day × 5 days) administered with intravenous paclitaxel (175 mg/m 2 as a 3-hour infusion on day 1) in advanced NSCLC patients. The maximum tolerated dose of oral topotecan will be reported, along with preliminary response...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2001) 61 (Suppl. 1): 25–29.
Published Online: 26 September 2001
...Penny O’Neill; Peter I. Clark; David Smith; Ernest Marshall; Kate Hannigan; Graham Ross A phase I dose-escalation study was undertaken to determine the maximum tolerated dose of the intravenous combination of topotecan and etoposide in previously untreated patients with small-cell lung cancer...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2001) 61 (Suppl. 1): 42–46.
Published Online: 26 September 2001
... toxicity was grade 1/2 in severity, and there were no discontinuations attributed to nonhematologic toxicity. In a patient population reflective of the general SCLC population (i.e. elderly with multiple comorbidities), oral topotecan was generally well tolerated at the lower dose level, with a preliminary...